Home Compliance Novartis and Alcon: A Review of Bribery and Accounting Violations (Part II... ComplianceExpert OpinionFCPANews Novartis and Alcon: A Review of Bribery and Accounting Violations (Part II of III) July 14, 2020 33 Share FacebookLinkedinTwitter Piotr Swat | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Defense Contractor Pleads Guilty to Bribery Conspiracy Worth More Than $100 Million Compliance CFIUS Update: Larger Penalties, Sharper Monitoring Compliance Who Needs FEPA?